infuse
-
INFUSE Bone Graft Remains Important Treatment Option
MINNEAPOLIS – June 17, 2013 – Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings from Yale University’s third-party, independent review…
Read More » -
Biologics
Medtronic receives notification that U.S. Department Of Justice and U.S. Attorney’s office have closed their investigation of activities relating to Infuse® bone graft
MINNEAPOLIS – MAY 16, 2012 – Medtronic, Inc. (NYSE: MDT) today announced it has been notified by the U.S. Department of Justice (DOJ) and the…
Read More » -
More shareholders sue Medtronic over Infuse claims
Medtronic (NYSE:MDT) found itself at the center of another shareholder lawsuit accusing it of artificially boosting its stock price and…
Read More » -
Could Black Bear Blood Replace Infuse?
Black bear blood sounds like a bizarre source for a bone growth enhancer. However, Aursos, Inc. a Michigan-based company, is…
Read More » -
Senators press Medtronic for device info
WASHINGTON – Three U.S. senators have asked Fridley-based Medtronic Inc. to supply detailed information about how the company keeps track…
Read More » -
Medtronic deals with questions of biased research
In a strong course of action, The Spine Journal recently dedicated its entire June issue to a review of recombinant…
Read More » -
Spine
Infuse Furor May Force Medtronic Spine Business Sale. Who Would Buy?
A Wall Street analyst is speculating that Medtronic‘s (NYSE:MDT ) woes over its blockbuster Infuse product might lead the medical device company…
Read More » -
Biologics
Spine Experts Repudiate Medtronic Studies
In an extraordinary move, a group of spine specialists are publicly repudiating the research of other experts that has backed…
Read More » -
Biologics
Medtronic’s Infuse Off-Label, Doctor Payment Woes; Senate Probe
Medtronic is in trouble regarding its Infuse spine surgery product which was approved by the FDA in 2009 but has…
Read More » -
Spine
NYT: Medtronic spinal product faces widening probe
Medtronic Inc. products used to help bone growth in spinal-fusion procedures are facing growing scrutiny by both the FDA and…
Read More »